Cargando…

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents

Detalles Bibliográficos
Autores principales:	Higashi, Michiko, Tamura, Takahiro, Adachi, Yushi U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967098/ https://www.ncbi.nlm.nih.gov/pubmed/32026962 http://dx.doi.org/10.1186/s40981-019-0253-y

Ejemplares similares

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Byum, et al.
Publicado: (2017)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Prolonged neuromuscular blockade in a middle-eastern female patient homozygous for atypical plasma cholinesterase
por: Rico-Mora, David A., et al.
Publicado: (2018)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent
por: Zhang, Xiangjun, et al.
Publicado: (2019)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

Asystole Following Neuromuscular Blockade Reversal in Cardiac Transplant Patients
por: Nkemngu, Njinkeng J
Publicado: (2017)

Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
por: Samara, Evangelia, et al.
Publicado: (2020)

Potentially disastrous reversal of neuromuscular block agents before removing Mayfield head holder
por: Santos, Christiano dos Santos e, et al.
Publicado: (2020)

A surgeon’s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
por: Lamberg, James J, et al.
Publicado: (2013)

Neuromuscular blockade: The importance of T.O.F. (Think outside the frame!)
por: Agrò, Felice Eugenio, et al.
Publicado: (2019)

General anesthesia without neuromuscular blockade for a child with mitochondrial myopathy
por: Jeon, Younghoon, et al.
Publicado: (2012)

Interdisciplinary intraoperative communication and collaboration needed for optimal neuromuscular blockade management
por: Welliver, Mark D., et al.
Publicado: (2014)

Sedation, narcotic and neuromuscular blockade in mechanically ventilated patients with COVID-19
por: Rizvi, Ghazi, et al.
Publicado: (2021)

Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis
por: Oh, Young-Jae, et al.
Publicado: (2013)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

In response: Interdisciplinary intraoperative communication and collaboration needed for optimal neuromuscular blockade management
por: Answine, Joseph F, et al.
Publicado: (2014)

Prolonged neuromuscular block associated with cholinesterase deficiency
por: Zhang, Chao, et al.
Publicado: (2018)

Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Factors involved in prolonged effect of neuromuscular blockade in therapeutic hypothermia
por: Tanaka, H, et al.
Publicado: (2014)

Management of robotic partial nephrectomy in a patient with myasthenia gravis: General anaesthesia sans neuromuscular blocking agent
por: Ashokananda, Devanahalli, et al.
Publicado: (2022)

Survey on neuromuscular management
por: Chacko, Cyril Jacob, et al.
Publicado: (2016)

Monitoring of neuromuscular blockade by pulse oximetry tracing: A simple modification of mechanomyographic and acceleromyographic principles
por: Das, Jyotirmoy, et al.
Publicado: (2011)

Reply to “Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?”
por: Ji, Wentao, et al.
Publicado: (2022)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study
por: Grosse-Sundrup, Martina, et al.
Publicado: (2012)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
por: Domenech, Gonzalo, et al.
Publicado: (2019)

The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
por: Kim, Hyunho, et al.
Publicado: (2022)

General anesthesia using remimazolam and remifentanil in combination with local anesthetics without neuromuscular blocking agents in a patient with myotonic dystrophy
por: Koyama, Yukihide, et al.
Publicado: (2023)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

COVID-19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2021)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Paredes, Stephania, et al.
Publicado: (2023)

Fatigue is part of the burden of neuromuscular diseases
por: Wokke, J. H. J.
Publicado: (2007)

Comments on “Neuromuscular Ultrasonography of Cranial Nerves”
por: Tenuta, Maurizio, et al.
Publicado: (2017)

Neuromuscular Involvement in COVID-19 Patients
por: Finsterer, Josef
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ue9peahqlmeek4f5pl7pgpkvjl